Durability of PARP Inhibition: Implications for Dose & Schedule as Single Agent & Combination Therapy
Time: 3:00 pm
day: Day Two
- Understanding different PARPi doses and schedules are needed for single agent and combinations
- Delving into how the durability of PARP inhibition differs for the approved PARPis
- Is the MTD/Safe dose and schedule appropriate for the approved dose of a molecularly targeted agent?
- Clinical implications and improving access
This seminar will be streamed live at the event